Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-19 Hunt Anthony Chief Executive Officer Sale −2,819 $174.41 $492K 190,875
2021-05-19 Hunt Anthony Chief Executive Officer Sale −380 $175.15 $67K 190,495
2021-05-14 Gebski Christine Sale −445 $172.25 $77K 36,695
2021-05-14 KURIYEL RALF Senior VP, R&D Sale −710 $172.29 $122K 24,555
2021-05-14 Snodgres Jon Chief Financial Officer Sale −470 $172.60 $81K 31,893
2021-05-13 EGLINTON MANNER CARRIE Director Grant or award +457 457
2021-05-13 EGLINTON MANNER CARRIE Director Grant or award · Stock Option (Right to Buy) +1,151 1,151
2021-05-13 MUIR GLENN P Director Grant or award +457 6,362
2021-05-13 MUIR GLENN P Director Grant or award · Stock Option (Right to Buy) +1,151 1,151
2021-05-13 BARTHELEMY NICOLAS Director Grant or award +457 1,907
2021-05-13 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +1,151 1,151
2021-05-13 RYAN THOMAS F JR Director Grant or award +457 1,751
2021-05-13 RYAN THOMAS F JR Director Grant or award · Stock Option (Right to Buy) +1,151 1,151
2021-05-13 Mhatre Rohin Director Grant or award +457 457
2021-05-13 Mhatre Rohin Director Grant or award · Stock Option (Right to Buy) +1,151 1,151
2021-05-13 DAWES KAREN A Director Grant or award +604 116,053
2021-05-13 DAWES KAREN A Director Grant or award · Stock Option (Right to Buy) +1,522 1,522
2021-05-11 DAWES KAREN A Director Exercise or conversion +15,000 $3.22 $48K 115,734
2021-05-11 DAWES KAREN A Director Sale −285 $176.85 $50K 115,449
2021-05-11 DAWES KAREN A Director Exercise or conversion · Stock Option (Right to Buy) −15,000 0

Page 28 of 42 · 832 trades